FMP

FMP

Blog
Screener
Extras

CLBS - Caladrius Biosciences, Inc.

Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or

photo-url-https://financialmodelingprep.com/image-stock/CLBS.jpg

Caladrius Biosciences, Inc.

CLBS

NASDAQ

0.43 USD

-0.08579999 (-20.12%)

About

ceo

Dr. David Mazzo

sector

Healthcare

industry

Biotechnology

website

https://www.caladrius.com

exchange

NASDAQ

Description

Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. Caladrius Biosciences...

CIK

0000320017

ISIN

US1280582032

CUSIP

128058203

Address

110 Allen Rd

Phone

19088420100

Country

US

Employee

27

IPO Date

Nov 3, 1995

Summary

CIK

0000320017

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

128058203

ISIN

US1280582032

Country

US

Price

0.43

Beta

0.91

Volume Avg.

0

Market Cap

3.35M

Shares

-

52-Week

-

DCF

2.06

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-1.08

P/B

-

Website

https://www.caladrius.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest CLBS News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep